Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Infliximab Originator, Infliximab Biosimilar, and Adalimumab Are More Effective in Crohn's Disease Than Ulcerative Colitis: A Real-Life Cohort Study.
Barberio B, Zingone F, D'Incà R, Rovigo L, Bertani L, Bodini G, Ghisa M, Gubbiotti A, Massimi D, Lorenzon G, Savarino EV. Barberio B, et al. Among authors: gubbiotti a. Clin Transl Gastroenterol. 2020 May;11(5):e00177. doi: 10.14309/ctg.0000000000000177. Clin Transl Gastroenterol. 2020. PMID: 32677808 Free PMC article.
Serum Levels of PCSK9 Are Increased in Patients With Active Ulcerative Colitis Representing a Potential Biomarker of Disease Activity: A Cross-sectional Study.
Marinelli C, Zingone F, Lupo MG, Marin R, D'Incà R, Gubbiotti A, Massimi D, Casadei C, Barberio B, Ferri N, Savarino E. Marinelli C, et al. Among authors: gubbiotti a. J Clin Gastroenterol. 2022 Oct 1;56(9):787-793. doi: 10.1097/MCG.0000000000001607. Epub 2021 Sep 22. J Clin Gastroenterol. 2022. PMID: 34560758 Free PMC article.
Association between Ustekinumab Trough Levels, Serum IL-22, and Oncostatin M Levels and Clinical and Biochemical Outcomes in Patients with Crohn's Disease.
Bertin L, Barberio B, Gubbiotti A, Bertani L, Costa F, Ceccarelli L, Visaggi P, Bodini G, Pasta A, Sablich R, Urbano MT, Ferronato A, Buda A, De Bona M, Del Corso G, Massano A, Angriman I, Scarpa M, Zingone F, Savarino EV. Bertin L, et al. Among authors: gubbiotti a. J Clin Med. 2024 Mar 7;13(6):1539. doi: 10.3390/jcm13061539. J Clin Med. 2024. PMID: 38541765 Free PMC article.
Key factors for improving adenoma detection rate.
Gubbiotti A, Spadaccini M, Badalamenti M, Hassan C, Repici A. Gubbiotti A, et al. Expert Rev Gastroenterol Hepatol. 2022 Sep;16(9):819-833. doi: 10.1080/17474124.2022.2128761. Epub 2022 Oct 14. Expert Rev Gastroenterol Hepatol. 2022. PMID: 36151898 Review.
Thyroid dysfunction in COVID-19 patients.
Baldelli R, Nicastri E, Petrosillo N, Marchioni L, Gubbiotti A, Sperduti I, Di Giacinto P, Rizza L, Rota F, Franco M, Lania A, Aimaretti G, Ippolito G, Zuppi P. Baldelli R, et al. Among authors: gubbiotti a. J Endocrinol Invest. 2021 Dec;44(12):2735-2739. doi: 10.1007/s40618-021-01599-0. Epub 2021 Jun 8. J Endocrinol Invest. 2021. PMID: 34101132 Free PMC article.
Hydrophobically gated memristive nanopores for neuromorphic applications.
Paulo G, Sun K, Di Muccio G, Gubbiotti A, Morozzo Della Rocca B, Geng J, Maglia G, Chinappi M, Giacomello A. Paulo G, et al. Among authors: gubbiotti a. Nat Commun. 2023 Dec 18;14(1):8390. doi: 10.1038/s41467-023-44019-y. Nat Commun. 2023. PMID: 38110352 Free PMC article.
26 results